{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:26:22Z","timestamp":1791923182378,"version":"4.3.4"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Ovarian clear cell carcinoma (OCCC) frequently arises in association with endometriosis and is characterized by iron-rich oxidative stress, hypoxia-responsive metabolic reprogramming, glycogen accumulation, and alterations in ferroptosis-regulatory pathways. Interactions among hypoxia, iron metabolism, oxidative stress, and ferroptosis are increasingly recognized, but their role during precursor evolution remains uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis<\/jats:title>\n                    <jats:p>\n                      We propose that chronic iron-rich oxidative stress and a hypoxic microenvironment may jointly alter the relative fitness of epithelial cells during the endometriosis-to-OCCC transition. Repeated exposure may create a putative ferroptosis-related selection filter that preferentially removes susceptible cells while enriching less-susceptible cellular subpopulations capable of sustained survival. Here, ferroptosis tolerance denotes relative survival under chronic or sublethal ferroptosis-related stress and does not imply experimentally demonstrated resistance; broader oxidative-stress adaptation alone is insufficient to establish it. Surviving populations may acquire an adaptive iron-handling state that constrains the metabolically available labile iron pool despite an iron-rich extracellular environment through changes in iron uptake, ferritin-mediated sequestration and turnover, mitochondrial utilization, cellular export, or extracellular-vesicle-mediated ferritin disposal. These mechanisms may cooperate with HIF-1\u03b1\/SLC1A1-associated adaptation and NRF2\/SLC7A11\/GPX4\/glutathione pathways. Loss-of-function alteration of\n                      <jats:italic>ARID1A<\/jats:italic>\n                      may contribute to oncogenic evolution, while ARID1A deficiency may also modify redox and ferroptotic vulnerability and thereby the intensity of selection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The novelty of this framework lies not in any single molecular interaction, but in applying interconnected iron, hypoxia, redox, and ferroptosis biology to an evolutionary selection model across the endometriosis\u2013atypical endometriosis\u2013OCCC continuum. The model predicts coordinated stress and iron-handling adaptations in precursor lesions, reproducible changes in population composition after repeated sublethal iron\u2013hypoxia exposure, and, as a distinct outcome, durable phenotypic adaptation after washout. These predictions can be tested through cyst-fluid analysis, spatial profiling, and repeated-exposure, washout, rechallenge, and lineage-tracing experiments. The framework is a falsifiable hypothesis that may be supported, narrowed, reformulated, or rejected experimentally.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1965365","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:28:29Z","timestamp":1789532909000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["A coupled iron-hypoxia selection model for the evolution of endometriosis-associated ovarian clear cell carcinoma"],"prefix":"10.3389","volume":"16","author":[{"given":"Yasushi","family":"Umezaki","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Saga University","place":["Saga, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoichi","family":"Okuma","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Saga University","place":["Saga, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asako","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Saga University","place":["Saga, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Kamishita","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Saga University","place":["Saga, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Kurihara","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Saga University","place":["Saga, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukine","family":"Satomi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Saga University","place":["Saga, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Okugawa","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Saga University","place":["Saga, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2019.03.243","article-title":"Trends and characteristics of epithelial ovarian cancer in Japan between 2002 and 2015: A JSGO\u2013JSOG joint study","volume":"153","author":"Machida","year":"2019","journal-title":"Gynecol Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2008.00747.x","article-title":"Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma","volume":"99","author":"Itamochi","year":"2008","journal-title":"Cancer Sci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2217\/fon.15.45","article-title":"Molecular pathogenesis of ovarian clear cell carcinoma","volume":"11","author":"Gounaris","year":"2015","journal-title":"Future Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3892\/or_00000429","article-title":"Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (Review)","volume":"22","author":"Kobayashi","year":"2009","journal-title":"Oncol Rep"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0b013e318222cfdd","article-title":"Redox-active iron-induced oxidative stress in the pathogenesis of clear cell carcinoma of the ovary","volume":"21","author":"Yamada","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3233\/CBM-150484","article-title":"Cyst fluid iron-related compounds as useful markers to distinguish Malignant transformation from benign endometriotic cysts","volume":"15","author":"Yoshimoto","year":"2015","journal-title":"Cancer biomark"},{"key":"B7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1158\/1078-0432.CCR-07-1614","article-title":"Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress","volume":"14","author":"Yamaguchi","year":"2008","journal-title":"Clin Cancer Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112945","article-title":"HIF-1\u03b1 drives resistance to ferroptosis in solid tumors by promoting lactate production and activating SLC1A1","volume":"42","author":"Yang","year":"2023","journal-title":"Cell Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0b013e318237d66c","article-title":"Aberrant expression of the mammalian target of rapamycin, hypoxia-inducible factor 1\u03b1, and glucose transporter 1 in the development of ovarian clear-cell adenocarcinoma","volume":"31","author":"Kato","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2017.04.115","article-title":"Iron regulatory protein 2 in ovarian endometrial cysts","volume":"487","author":"Takenaka","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-22-1294","article-title":"Endometriosis-associated mesenchymal stem cells support ovarian clear cell carcinoma through iron regulation","volume":"82","author":"Atiya","year":"2022","journal-title":"Cancer Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.70341","article-title":"HIF2A as a prognostic and clinical therapeutic target in ovarian clear cell carcinoma","volume":"158","author":"Jiang","year":"2026","journal-title":"Int J Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/gaad046","article-title":"Endometrial stromal cell autophagy-dependent ferroptosis caused by iron overload in ovarian endometriosis is inhibited by the ATF4-xCT pathway","volume":"30","author":"Dong","year":"2024","journal-title":"Mol Hum Reprod"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.930614","article-title":"Ferroptosis induced by iron overload promotes fibrosis in ovarian endometriosis and is related to subpopulations of endometrial stromal cells","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Pharmacol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2026.101098","article-title":"Transcriptomic landscape of coexisting ovarian clear cell carcinoma and endometriosis: Insights into Malignant transformation","volume":"46","author":"Shibata","year":"2026","journal-title":"Cancer Treat Res Commun"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/848595","article-title":"Oxidative stress and antioxidant defense in endometriosis and its Malignant transformation","volume":"2015","author":"Iwabuchi","year":"2015","journal-title":"Oxid Med Cell Longev"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2019.7850","article-title":"Cysteine deprivation targets ovarian clear cell carcinoma via oxidative stress and iron-sulfur cluster biogenesis deficit","volume":"33","author":"Novera","year":"2020","journal-title":"Antioxid Redox Signal"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176544","article-title":"Involvement of ferroptosis in eribulin-induced cytotoxicity in ovarian clear cell carcinoma","volume":"971","author":"Azumi","year":"2024","journal-title":"Eur J Pharmacol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2016.1187366","article-title":"Autophagy promotes ferroptosis by degradation of ferritin","volume":"12","author":"Hou","year":"2016","journal-title":"Autophagy"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1532097","article-title":"Expulsion of iron-rich ferritin via CD63-mediated exosome drives ferroptosis resistance in ovarian cancer cells","volume":"13","author":"Battaglia","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.redox.2015.03.003","article-title":"Expression of xCT and activity of system xc- are regulated by NRF2 in human breast cancer cells in response to oxidative stress","volume":"5","author":"Habib","year":"2015","journal-title":"Redox Biol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/mc.22072","article-title":"Hepatocyte nuclear factor-1\u03b2 (HNF-1\u03b2) promotes glucose uptake and glycolytic activity in ovarian clear cell carcinoma","volume":"54","author":"Okamoto","year":"2015","journal-title":"Mol Carcinog"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1008433","article-title":"ARID1A mutations in endometriosis-associated ovarian carcinomas","volume":"363","author":"Wiegand","year":"2010","journal-title":"N Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"14260","DOI":"10.1038\/s41598-020-71273-7","article-title":"ARID1A protein expression is retained in ovarian endometriosis with ARID1A loss-of-function mutations: implication for the two-hit hypothesis","volume":"10","author":"Yachida","year":"2020","journal-title":"Sci Rep"},{"key":"B28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ccell.2018.12.009","article-title":"Targeting the vulnerability of glutathione metabolism in ARID1A-deficient cancers","volume":"35","author":"Ogiwara","year":"2019","journal-title":"Cancer Cell"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000035301","article-title":"Clinicopathological correlations of endometrioid and clear cell carcinomas in the uterus and ovary","volume":"102","author":"Mori","year":"2023","journal-title":"Med (Baltimore)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.31083\/FBL39675","article-title":"Iron fist in a velvet glove: class IV ferroptosis inducers as a novel strategy to target ovarian cancer","volume":"30","author":"Petriaggi","year":"2025","journal-title":"Front Biosci (Landmark Ed)"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1965365\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:28:29Z","timestamp":1789532909000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1965365\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":30,"alternative-id":["10.3389\/fonc.2026.1965365"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1965365","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"article-number":"1965365"}}